Companies must be more aggressive in self-disrupting, says Warren Ackerman, head of European consumer staples research at ...
Check out these key takeaways from a recent supply chain panel featuring leaders from prominent companies in the high-tech, retail, and consumer products industries.
One area that medical device manufacturers often overlook in post-market surveillance (PMS) planning for EU MDR and EU IVDR ...
“Companies are realizing that investing stateside can provide more control and resilience to the drug supply chain,” says Dymowski. She cites political tensions, import and export disruptions, and ...
Mondelez is also having to deal with cost inflation in its supply chain in respect to “unprecedented” cocoa prices.